Atlantic Equities

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen Analyst Brian Abrahams maintained an Outperform rating, while raising the price...

Johnson & Johnson (NYSE: JNJ) reported a 3% growth in net sales to $24.02 billion, surpassing the consensus estimate of $23.81 billion, and a 4.4% growth in adjusted earnings to $2.59 per share, beating Street expectations of $2.57 per share. Raymond James On Johnson & Johnson: Analyst...

Intel Corporation's (NASDAQ: INTC) turnaround efforts under the new CEO Pat Gelsinger have not elicited much confidence among sell-side analysts. An analyst at Atlantic Equities Monday lowered his opinion on the shares. The Intel Analyst: Ianjit Bhatti downgraded Intel shares from Neutral to...

Snap Inc (NYSE: SNAP) shares are advancing strongly Tuesday on the back of a positive analyst action. The Snap Analyst: Atlantic Equities analyst James Cordwell upgraded Snap shares from Neutral to Outperform, while maintaining the price target at $75. The Snap Thesis: The recent pullback in...

Snap Inc (NYSE: SNAP) reported fourth-quarter revenue short of expectations, but earnings came in ahead on the back of strong user growth and continued margin expansion, according to Atlantic Equities. The Analyst James Cordwell upgraded Snap from Underweight to Neutral, while raising the price...

The Coca-Cola Co (NYSE: KO) and PepsiCo, Inc. (NASDAQ: PEP) both enjoy an attractive market share across attractive categories so there is "merit" to owning either stock, according to Atlantic Equities. The Analyst Atlantic Equities' Edward Lewis initiated coverage of Coca-Cola's...

Tiffany & Co (NYSE: TIF) has taken a huge hit in the past six months, but one Wall Street analyst said Thursday the discounted valuation provides an excellent buying opportunity. The Analyst Atlantic Equities analyst Daniela Nedialkova upgraded Tiffany from Neutral to Overweight and reiterated...

Video game maker Electronic Arts, Inc. (NASDAQ: EA) reported second-quarter earnings Tuesday that largely exceeded projections. The Analysts MKM Partners analyst Eric Handler maintained a Buy rating on EA and lowered the price target from $157 to $135. Atlantic Equities analyst Kunaal Malde...

TJX Companies Inc (NYSE: TJX) shares are up 24 percent year to-date, but now appear fairly valued, according to Atlantic Equities.  The Analyst  Analyst Daniela Nedialkova downgraded TJX from Overweight to Neutral with a $90 price target.  The Thesis TJX has been on a solid...

Pre-open movers U.S. stock futures traded higher in early pre-market trade. Data on nonfarm productivity and unit labor costs for the first quarter and the international trade report for April will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average climbed 106 points to 24,...

Pre-open movers U.S. stock futures traded higher in early pre-market trade, ahead of earnings reports from several companies. Data on retail sales for January and the Consumer Price Index for January will be released at 8:30 a.m. ET. Data on business inventories for December will be released at 10:...

Amid all-time high territory, Apple Inc. (NASDAQ: AAPL) was hit with a downgrade Monday, due to a wave of new challenges that may limit future upside. The Analyst James Cordwell of Atlantic Equities downgraded Apple from Overweight to Neutral, but kept his $190 price target. The Thesis...

By many measures 2017 was a decent year for airline investors, but heading into 2018 one name sticks out as best in class: Southwest Airlines Co (NYSE: LUV). The Analyst Atlantic Equities' Lindsay Bettiol upgraded Southwest Airlines' stock from Neutral to Overweight with a price...

Pre-open movers U.S. stock futures traded higher in early pre-market trade. Data on initial jobless claims for the latest week, retail sales for November and import prices for November will be released at 8:30 a.m. ET. The flash Composite Purchasing Managers' Index for December is schedule for...

Just a day after Credit Suisse reinstated an Outperform rating on Johnson & Johnson (NYSE: JNJ) based on future gain from Actelion, BTIG and Atlantic Equities downgraded the stock from Neutral to Sell and Underweight, respectively, for nearly the opposite reason. Atlantic Equities: Weak Setup...